Energy Metabolism in Residents in the Low- and Moderate Altitude Regions of Central Asia with MAFLD and Type 2 Diabetes Mellitus

Abstract

The knowledge about the features of energy metabolism in MAFLD in the population living at different climatic and geographic heights is lacking. The goal of this study is to explore the biochemical parameters of blood and erythrocyte energy consumption in patients with MAFLD with and without DM2 living in the low- and moderate-altitude regions of Central Asia. Our study was carried out on patients living in low-altitude mountains: Bishkek, altitude=750–800 m; n=67 (MAFLD with DM 2: n=24; MAFLD without DM2: n=25; control: n=18), and At-Bashy District, Naryn Region, altitude=2046–2300 m; n=58 (MAFLD with DM2: n=28; MAFLD without DM2: n=18; control: n=12). Non-alcoholic fatty liver disease was diagnosed according to history, laboratory tests, liver ultrasound, and exclusion of other liver diseases. The level of liver fibrosis was determined using the FIB-4 score. Blood adenosine 5′-triphosphate (ATP) was determined using the CellTiter-Glo method. Healthy residents living in moderate altitudes have significantly higher levels of cytosolic ATP in their blood (p+≤+0.05) than residents living in low mountains. MAFLD is characterized by an increase in the level of ATP concentration in their blood. ATP concentration decreased significantly in patients with MAFLD with DM2 living in moderate-altitude in comparison to those living in low-altitude mountains. The results suggest that chronic altitude hypoxia leads to a breakdown in adaptive mechanisms of energy metabolism of ATP in patients with MAFLD with type 2 DM.

Keywords

fatty liver disease - ATP - diabetes mellitus

Publication History

Received: 01 October 2023

Accepted after revision: 28 January 2024

Article published online:
19 February 2024

• References

• 1 Younossi ZM, Koenig AB, Abdelatif D. et al. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 2016; 64: 73-84
• 2 Lin H, Zhang X, Li G. et al. Epidemiology and Clinical Outcomes of Metabolic (Dysfunction)-associated Fatty Liver Disease. J Clin Transl Hepatol 2021; 9: 972-982
• 3 Chatterjee S, Khunti K, Davies MJ. Type 2 diabetes. Lancet 2017; 389: 2239-2251 Erratum: Lancet 2017; 389: 2192
• 4 Loomba R, Wong R, Fraysse J. et al. Nonalcoholic fatty liver disease progression rates to cirrhosis and progression of cirrhosis to decompensation and mortality: a real world analysis of medicare data. Aliment Pharmacol Ther 2020; 51: 1149-1159
• 5 Ye J. Mechanism of insulin resistance in obesity: a role of ATP. Front Med 2021; 15: 372-382
• 6 Garrafa E, Segala A, Vezzoli M. et al. Mitochondrial dysfunction in peripheral blood mononuclear cells as novel diagnostic tools for non-alcoholic fatty liver disease: visualizing relationships with known and potential disease biomarkers. Diagnostics 2023; 13: 2363
• 7 Groen MB, Knudsen TA, Finsen SH. et al. Reduced skeletal-muscle perfusion and impaired ATP release during hypoxia and exercise in individuals with type 2 diabetes. Diabetologia 2019; 62: 485-493
• 8 Zhou Z, Mahdi A, Tratsiakovich Y. et al. Erythrocytes from patients with Type 2 Diabetes induce endothelial dysfunction via arginase I. J Am Coll Cardiol 2018; 72: 769-780
• 9 Sprague RS, Goldman D, Bowles EA. et al. Divergent effects of low-O₂ tension and iloprost on ATP release from erythrocytes of humans with type 2 diabetes: implications for O₂ supply to skeletal muscle. Am J Physiol Heart Circ Physiol 2010; 299: H566-H573
• 10 Benedik PS, Hamlin SK. The physiologic role of erythrocytes in oxygen delivery and implications for blood storage. Critical Care Nurs Clin North Am 2014; 26: 325-335
• 11 Sprague RS, Ellsworth ML. Erythrocyte-derived ATP and perfusion distribution: role of intracellular and intercellular communication. Microcirculation 2012; 19: 430-439
• 12 Latshang TD, Furian M, Aeschbacher SS. et al. Association between sleep apnoea and pulmonary hypertension in Kyrgyz highlanders. Eur Respir J 2017; 49: 1601530
• 13 Roth GA, Johnson C, Abajobir A. et al. Global, regional and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. J Am Coll Cardiol 2017; 70: 1-25
• 14 Nurgul T, Eftekhari P, Breidert M. et al Features of metabolic associated fatty liver disease in the central Asian population in low and high altitude. Z Gastroenterol 2022; 60: 08 KA363
• 15 Bärtsch P, Saltin B. General introduction to altitude adaptation and mountain sickness. Scand J Med Sci Sport 2008; 18: 1-10
• 16 Lahav Y, Epstein Y, Kedem R. et al. A novel body circumferences-based estimation of percentage body fat. Br J Nutr 2018; 119: 720-725
• 17 Imamura H, Nhat KP, Togawa H. et al. Visualization of ATP levels inside single living cells with fluorescence resonance energy transfer-based genetically encoded indicators. Proc Natl Acad Sci USA 2009; 106: 15651-15656
• 18 Roda A, Pasini P, Mirasoli M. et al. Biotechnological applications of bioluminescence and chemiluminescence. Trends Biotechnol 2004; 2: 295-303
• 19 Forrester T, Williams CA. Release of adenosine triphosphate from isolated adult heart cells in response to hypoxia. J Physiol 1977; 268: 371-390
• 20 Dalziel HH, Westfall DP. Receptors for adenine nucleotides and nucleosides: subclassification, distribution, and molecular characterization. Pharmacol Rev 1994; 46: 449-466
• 21 Dietrich HH, Ellsworth ML, Sprague RS. et al. Red blood cell regulation of microvascular tone through adenosine triphosphate. Am J Physiol Heart Circ Physiol 2000; 278: H1294-H1298
• 22 Olearczyk JJ, Stephenson AH, Lonigro AJ. et al. NO Inhibits signal transduction pathway for ATP release from erythrocytes via its action on heterotrimeric G protein Gi. Am J Physiol Heart Circ Physiol 2004; 287: H748-H754
• 23 Sprague RS, Olearczyk JJ, Spence DM. et al. Extracellular ATP signaling in the rabbit lung: erythrocytes as determinants of vascular resistance. Am J Physiol Heart Circ Physiol 2003; 285: H693-H700
• 24 Ellsworth ML. The red blood cell as an oxygen sensor: what is the evidence?. Acta Physiol Scand 2000; 168: 551-559
• 25 Ellsworth ML. Red blood cell-derived ATP as a regulator of skeletal muscle perfusion. Med Sci Sports Exerc 2004; 36: 35-41
• 26 Ellsworth ML, Forrester T, Ellis CG. et al. The erythrocyte as a regulator of vascular tone. Am J Physiol Heart Circ Physiol 1995; 269: H2155-H2161
• 27 Gonzalez-Alonzo J, Olsen DB, Saltin B. Erythrocyte and the regulation of human skeletal muscle blood flow and oxygen delivery. Circ Res 2000; 91: 1046-1055
• 28 Olearczyk JJ, Stephenson AH, Lonigro AJ. et al. Heterotrimeric G protein Gi is involved in a signal transduction pathway for ATP release from erythrocytes. Am J Physiol Heart Circ Physiol 2004; 286: H940-H945
• 29 Sprague RS, Stephenson AH, Bowles EA. et al. Reduced expression of Gi in erythrocytes of humans with diabetes type 2 is associated with impairment of both cAMP generation and ATP release. Diabetes 2006; 55: 3588-3593
• 30 Rozier MD, Zata VJ, Ellsworth ML. Lactate interferes with ATP release from red blood cells. Am J Physiol Heart Circ Physiol 2007; 292: H3038-H3042
• 31 Goedeke L, Shulman GI. Therapeutic potential of mitochondrial uncouplers for the treatment of metabolic associated fatty liver disease and NASH. Mol Metab 2021; 46: 101178